## Abstract ## Purpose To determine the utility of MRI for assessing axillary lymph node status in patients with breast cancer. ## Materials and Methods A consecutive series of patients who underwent breast MR before surgical management of breast cancer with axillary sampling between 2005 and 20
USPIO-enhanced magnetic resonance imaging for nodal staging in patients with head and neck cancer
✍ Scribed by Luís Curvo-Semedo; Mónica Diniz; Jorge Miguéis; Maria-José Julião; Paula Martins; Alda Pinto; Filipe Caseiro-Alves
- Publisher
- John Wiley and Sons
- Year
- 2006
- Tongue
- English
- Weight
- 660 KB
- Volume
- 24
- Category
- Article
- ISSN
- 1053-1807
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Purpose
To determine the accuracy of ultrasmall superparamagnetic iron oxide (USPIO)‐enhanced magnetic resonance imaging (MRI) for nodal staging in patients with head and neck cancer.
Materials and Methods
Twenty patients with carcinomas of the upper aerodigestive tract were prospectively enrolled. MRI was performed before and 24–36 hours after intravenous infusion of an USPIO agent, ferumoxtran‐10 (Sinerem; Guerbet, France; and Combidex; Advanced Magnetics) at a dose of 2.6 mg Fe/kg using T2‐weighted spin‐echo and gradient‐echo sequences. Surgery was performed the same day or the day after the ferumoxtran‐10–enhanced MR examination. Based on MRI, selected nodes were surgically removed and directly correlated with pathology using hematoxylin‐eosin (H&E) and Perls stainings.
Results
A total of 63 nodes were studied; 36 were nonmetastatic, 25 metastatic, and two inflammatory. Ferumoxtran‐10–enhanced MRI allowed diagnosis of 24 metastatic and 30 nonmetastatic nodes, yielding a sensitivity of 96%, a specificity of 78.9%, a positive predictive value of 75%, and a negative predictive value of 96.8%, compared to 64%, 78.9%, 66.6%, and 76.9%, respectively, for nonenhanced MRI. Accuracy of ferumoxtran‐10–enhanced MRI was 85.7%. The gradient‐echo T2‐weighted sequence was the most accurate to detect signal loss in nonmetastatic nodes.
Conclusion
USPIO‐enhanced MRI is useful for nodal staging of patients with head and neck cancers. J. Magn. Reson. Imaging 2006. © 2006 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
Cytotoxic chemotherapy produces modest benefits for patients with recurrent and metastatic squamous cell carcinoma of the head and neck (SCCHN). Prospective randomized clinical trials have failed to demonstrate unequivocal superiority of aggressive multidrug regimens over single agents. Despite this
## Abstract ## Purpose To correlate permeability (rk~trans~), extracellular volume fraction (rv~e~), relative to muscle and initial area under the enhancement curve (IAUC~60m~) determined by dynamic contrast‐enhanced magnetic resonance imaging (DCE‐MRI) with in vivo measurements of interstitial fl